Nuclear receptor coregulator SNP discovery and impact on breast cancer risk

BackgroundCoregulator proteins are "master regulators", directing transcriptional and posttranscriptional regulation of many target genes, and are critical in many normal physiological processes, but also in hormone driven diseases, such as breast cancer. Little is known on how genetic changes in these genes impact disease development and progression. Thus, we set out to identify novel single nucleotide polymorphisms (SNPs) within SRC-1 (NCoA1), SRC-3 (NCoA3, AIB1), NCoR (NCoR1), and SMRT (NCoR2), and test the most promising SNPs for associations with breast cancer risk.MethodsThe identification of novel SNPs was accomplished by sequencing the coding regions of these genes in 96 apparently normal individuals (48 Caucasian Americans, 48 African Americans). To assess their association with breast cancer risk, five SNPs were genotyped in 1218 familial BRCA1/2-mutation negative breast cancer cases and 1509 controls (rs1804645, rs6094752, rs2230782, rs2076546, rs2229840).ResultsThrough our resequencing effort, we identified 74 novel SNPs (30 in NCoR, 32 in SMRT, 10 in SRC-3, and 2 in SRC-1). Of these, 8 were found with minor allele frequency (MAF) >5% illustrating the large amount of genetic diversity yet to be discovered. The previously shown protective effect of rs2230782 in SRC-3 was strengthened (OR = 0.45 [0.21-0.98], p = 0.04). No significant associations were found with the other SNPs genotyped.ConclusionsThis data illustrates the importance of coregulators, especially SRC-3, in breast cancer development and suggests that more focused studies, including functional analyses, should be conducted.

[1]  P. Bugert,et al.  A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. , 2009, Carcinogenesis.

[2]  Anna Frolov,et al.  Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression. , 2005, Cancer research.

[3]  Doheon Lee,et al.  SNP@Ethnos: a database of ethnically variant single-nucleotide polymorphisms , 2006, Nucleic Acids Res..

[4]  M. Beckmann,et al.  Association of ESR 1 gene tagging SNPs with breast cancer risk , 2009 .

[5]  D. Shi,et al.  Large replication study and meta-analyses of DVWA as an osteoarthritis susceptibility locus in European and Asian populations. , 2009, Human molecular genetics.

[6]  M. Dillon,et al.  Coassociation of Estrogen Receptor and p160 Proteins Predicts Resistance to Endocrine Treatment; SRC-1 is an Independent Predictor of Breast Cancer Recurrence , 2009, Clinical Cancer Research.

[7]  P. Saha,et al.  Absence of the SRC-2 Coactivator Results in a Glycogenopathy Resembling Von Gierke's Disease , 2008, Science.

[8]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[9]  Barbara Burwinkel,et al.  Association of NCOA3 Polymorphisms with Breast Cancer Risk , 2005, Clinical Cancer Research.

[10]  B. O’Malley.  Coregulators: from whence came these "master genes". , 2007, Molecular endocrinology.

[11]  C. Amos,et al.  Relative effects of mutability and selection on single nucleotide polymorphisms in transcribed regions of the human genome , 2008, BMC Genomics.

[12]  C. Semple,et al.  Chromatin structure and evolution in the human genome , 2007, BMC Evolutionary Biology.

[13]  B. Henderson,et al.  Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort , 2009, BMC Cancer.

[14]  Julian Peto,et al.  Association of ESR1 gene tagging SNPs with breast cancer risk. , 2009, Human molecular genetics.

[15]  B. O’Malley,et al.  The Expanding Cosmos of Nuclear Receptor Coactivators , 2006, Cell.

[16]  B. O’Malley,et al.  Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation , 2009, Proceedings of the National Academy of Sciences.

[17]  R. Lanz,et al.  Nuclear receptor coregulators and human disease. , 2008, Endocrine reviews.

[18]  J. Peto,et al.  The search for low-penetrance cancer susceptibility alleles , 2004, Oncogene.

[19]  T. Tamaya,et al.  Clinical implications of steroid receptor coactivator (SRC)-3 in uterine endometrial cancers , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[20]  B. O’Malley,et al.  Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation. , 2007, Molecular cell.

[21]  P. Radice,et al.  SNPs in ultraconserved elements and familial breast cancer risk. , 2009, Carcinogenesis.

[22]  J. Goldblatt,et al.  Does the relationship between IgE and the CD14 gene depend on ethnicity? , 2008, Allergy.